{"jsonapi":{"version":"1.0"},"data":{"type":"recalls","id":"03d4e16d35c615a69024c4a278f3ebe33eec05b68ef508704a20493e203bc53a","attributes":{"feedName":"medwatch","feedSource":"medwatch","title":"Risks Associated with Use of Rupture of Membranes Tests - Letter to Health Care Providers","description":"The FDA is reminding health care providers that tests to detect rupture of the amniotic membranes should not be used without other clinical assessments to make critical patient management decisions.","link":"https://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm616220.htm","publicationDate":"2018-08-08T18:00:00.000Z","state":"sent","affected":[],"allergens":[],"audience":["professionals"],"categories":["medical"],"contaminants":[],"distribution":["AL","AK","AZ","AR","CA","CO","CT","DE","DC","FL","GA","HI","ID","IL","IN","IA","KS","KY","LA","ME","MD","MA","MI","MN","MS","MO","MT","NE","NV","NH","NJ","NM","NY","NC","ND","OH","OK","OR","PA","RI","SC","SD","TN","TX","UT","VT","VA","WA","WV","WI","WY"],"risk":"none","token":"5d9e68838b079e002a2509aa"}}}